ACGT is particularly excited about #givingtuesday this year, as we unveil our new #NotImmune campaign. #NotImmune aims to put a spotlight on the need for funding research. #NotImmune is a call to action, Your opportunity to show family, friends and … Read More
Dr. Khalid Shah, Associate Professor at Harvard Medical School and 2007 ACGT Young Investigator was the first recipient of the Greenwich-Stamford Swim Across America Award. He has a new method for taking deadly brain tumors apart from the inside out … Read More
Dr. Carl H. June, whose original work was funded by ACGT, has expanded the number of patients who will benefit from his leukemia research. Current patients experiencing long remissions give the researchers hope that the treatment will have lasting effects. … Read More
“They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in,” Morrow said. Read More
I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More
Back in 2004, ACGT provided initial funding for the pioneering gene therapy research of Dr. Carl June of the Abramson Family Cancer Research Institute at the University of Pennsylvania. The research led to a therapy that uses the body’s own T-cells and turns them into weapons aimed directly at cancer. Read More
ACGT is the nation’s only non-profit exclusively dedicated to gene and cell therapies for treating cancer. To date, ACGT has provided over $24 million in grants to top oncologists and funded breakthrough clinical trials that save lives. Learn more about ACGT … Read More
Dr. Michel Sadelain, ACGT Research Fellow, talks about the future of gene therapies for cancer treatment. When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the Harvard Club in NYC. … Read More
Dr. Laurence Cooper, ACGT Research Fellow, emphasizes the need for philanthropy and private funding in the fight against cancer. . When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the … Read More
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.